Showing results (101-110 of 232) with videos related to
Sort By:
Pageof 24
Annals of Neurology|October 1, 1991
Pleuropulmonary disease associated with dopamine agonist therapyM H Bhatt, S P Keenan, J A Fleetham, et al.Annals of Neurology|October 1, 1989
Nigrostriatal function in humans studied with positron emission tomographyW R Martin, M R Palmer, C S Patlak, et al.Neurology|April 1, 1985
Dystonia and calcification of the basal gangliaT A Larsen, H G Dunn, J E Jan, et al.Neurology|June 1, 1989
A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's diseaseJ K Tsui, E C Wolters, R F Peppard, et al.Advances in Neurology|January 1, 1983
Methods for evaluating treatment in Parkinson's diseaseC D Ward, J N Sanes, J M Dambrosia, et al.Neurology|February 1, 1984
L-dopa decarboxylation in chronically treated patientsC D Ward, I K Trombley, D B Calne, et al.Clinical Pharmacology and Therapeutics|February 1, 1979
Bromocriptine inhibits norepinephrine releaseM G Ziegler, C R Lake, A C Williams, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 26, 1999
Occupational risk factors in Parkinson's diseaseJ K Tsui, D B Calne, Y Wang, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1991
The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomographyB J Snow, M Bhatt, W R Martin, et al.Pageof 24